Document is current

Any future updates will be listed below

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database

Crossref DOI link: https://doi.org/10.1186/s10194-024-01913-0

Published Online: 2024-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark